Markets

Insider Trading

Hedge Funds

Retirement

Opinion

5 Best UK Stocks to Buy According to Hedge Funds

In this article, we will list the 5 Best UK Stocks to Buy According to Hedge Funds. Please visit 12 Best UK Stocks to Buy According to Hedge Funds to Buy Now if you would like to see the extended list and the methodology behind it.

5. Rentokil Initial plc (NYSE:RTO)

On March 16, 2026, Citi analyst Marc Van’T Sant raised the price target on Rentokil Initial plc (NYSE:RTO) to 575 GBp from 550 GBp previously and maintained a Buy rating on the shares.

On March 12, 2026, UBS analyst Nicole Manion upgraded Rentokil to Buy from Neutral and raised the price target to 540 GBp from 430 GBp, marking the first positive stance since 2020. UBS said organic volumes appear set to return to growth and costs are stabilizing, suggesting a “valuable compounder could be re-emerging.” Oppenheimer also raised its price target on Rentokil Initial plc (NYSE:RTO) to $35 from $30 and maintained an Outperform rating, noting Q4 revenue of $1.7B was in line with expectations, supported by improving North America pest control trends, with FY26 tracking in line with consensus despite weather disruptions and geopolitical uncertainty.

Earlier, Rentokil reported 2025 revenue of $6.91B, up 2.6% organically and broadly in line with the $6.92B consensus estimate, while adjusted operating profit rose 5.4% to $1.07B with margins expanding to 15.5%. The company also said Chairman Richard Solomons plans to retire once a successor is appointed.

Rentokil Initial plc (NYSE:RTO) provides pest control and related route-based services across global markets.

4. Immunocore Holdings plc (NASDAQ:IMCR)

On March 16, 2026, Jefferies downgraded Immunocore Holdings plc (NASDAQ:IMCR) to Hold from Buy previously with a price target of $33, down from $48, after assuming coverage. Jefferies has said that Immunocore Holdings plc’s (NASDAQ:IMCR) lead product Kimmtrak addresses a “moderate” total addressable market in uveal melanoma and is nearing peak sales, adding that further upside now depends on pipeline success, where “shots on goal look risky.”

Last month, Immunocore Holdings plc (NASDAQ:IMCR) reported fourth-quarter EPS of (60c), below the (20c) consensus estimate. Revenue came in at $104.5M compared with the $107.77M consensus. Chief Executive Officer Bahija Jallal has said that Immunocore Holdings plc (NASDAQ:IMCR) delivered “a productive year of growth and progress” in 2025, supported by $400M in Kimmtrak sales and continued pipeline development. Bahija Jallal has added that 2026 will focus on executing clinical trials, with key data expected in oncology and the start of its first autoimmune study.

Immunocore Holdings plc (NASDAQ:IMCR) develops and commercializes immunomodulating therapies targeting cancer, infectious diseases, and autoimmune conditions.

3. Navigator Holdings Ltd. (NYSE:NVGS)

On March 19, 2026, Navigator Holdings Ltd. (NYSE:NVGS) announced that BW Group, its selling shareholder, is offering 7M shares in a secondary public offering, with the company not issuing any shares and receiving no proceeds. Navigator said it intends to repurchase 3.5M shares from the underwriters at the public offering price, though the buyback is not contingent on the completion of the offering. Citigroup, DNB Carnegie, Fearnley Securities, and Pareto Securities are acting as joint book-running managers. The deal was later increased to 8.0M shares from 7.0M and priced below the prior closing price of $19.17.

On March 13, 2026, Deutsche Bank raised its price target on Navigator Holdings Ltd. (NYSE:NVGS) to $25 from $24 previously and maintained a Buy rating, citing a fourth-quarter earnings beat and a positive outlook.

On March 11, 2026, Navigator Holdings Ltd. (NYSE:NVGS) reported preliminary fourth-quarter revenue of $152.83M versus the $136.15M consensus estimate and said total liquidity stood at $296.3M as of year-end 2025.

Navigator Holdings Ltd. (NYSE:NVGS) owns and operates a global fleet of vessels transporting liquefied gases, including petrochemical gases, LPG, and ammonia.

2. Janus Henderson Group plc (NYSE:JHG)

On March 24, 2026, Victory Capital Holdings, Inc. said it has withdrawn its proposal to acquire Janus Henderson Group plc (NYSE:JHG), stating it would only proceed with a negotiated transaction supported by Janus Henderson’s Special Committee. The company said it remains interested in Janus Henderson as a “high-quality organization” and continues to pursue acquisitions that enhance scale, product breadth, and global distribution.

On the same day, Janus Henderson Group plc (NYSE:JHG) announced an amended agreement with Trian Fund Management and General Catalyst, raising the offer price to $52.00 per share in cash. The revised terms also allow for a $1.00 per share quarterly dividend starting July 2026 if closing is delayed due to regulatory approvals. The company said the updated offer represents a 25% premium to its unaffected share price and remains on track to close by mid-2026. Janus Henderson added that its board, following the Special Committee’s recommendation, determined Victory’s latest proposal is not actionable due to “unacceptably high closing risks,” noting multiple prior proposals had failed to address similar concerns despite extensive discussions.

Janus Henderson Group plc (NYSE:JHG) is a global asset manager serving institutional and retail clients across equity and fixed income strategies.

1. Klarna Group plc (NYSE:KLAR)

On March 19, 2026, Klarna Group plc (NYSE:KLAR) announced that its Klarna Card has reached 5M active users globally, highlighting what the company described as “rapid adoption” as consumers shift toward more flexible payment options. Chief Marketing Officer David Sandstrom said the trend reflects how users are “looking for control and flexibility in a single card,” with the ability to choose between paying immediately or over time depending on the situation.

On March 17, 2026, Klarna Group plc (NYSE:KLAR) said it surpassed 1M merchants globally, with merchant count growing 47% over the past year, including 285,000 additions in 2025 and more than 115,000 in the fourth quarter alone. Chief Commercial Officer David Sykes said reaching this milestone reflects how Klarna is becoming more embedded in everyday spending, as consumers increasingly use its services across categories ranging from home-related purchases to recurring lifestyle expenses.

Earlier in March, BofA analyst Matthew O’Neill reinstated coverage on Klarna Group plc (NYSE:KLAR) with a Buy rating and a $21 price target.

Klarna Group plc (NYSE:KLAR) operates a digital banking and payments platform offering flexible payment solutions across global markets.

While we acknowledge the potential of KLAR to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than KLAR and that has 100x upside potential, check out our report about the cheapest AI stock.

READ NEXT: 10 Must-Buy Real Estate Stocks to Invest In and 11 Best High Volume Penny Stocks to Buy Now.

Disclosure: None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily e-newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.